Inventor · disambiguated record
Odile Piot-Grosjean
Also filed as: PIOT-GROSJEAN ODILE
4 granted patents·4 pending applications·34 citations·filing 2001–2007
75Inventor score
Files withAVENTIS PHARMA SA7
Top patents by PatentIndex Score
8 records- 0181US7148258B2Combination of a CB1 receptor antagonist and of sibutramine, the pharmaceutical compositions comprising them and their use in the treatment of obesityAVENTIS PHARMA SA·Filed 2004·Granted Dec 12, 2006·13 cites·11 claims
- 0281US7037944B2Combination of a CB1 receptor antagonist and of sibutramine, the pharmaceutical compositions comprising them and their use in the treatment of obesityAVENTIS PHARMA SA·Filed 2004·Granted May 2, 2006·13 cites·11 claims
- 0370US7217705B2Combination of a CB1 receptor antagonist and of a product which activates dopaminergic neurotransmission in the brain, the pharmaceutical compositions comprising them and their use in the treatment of parkinson's diseaseAVENTIS PHARMA SA·Filed 2004·Granted May 15, 2007·8 cites·7 claims
- 0467US2008058381A1Combination of a cb1 receptor antagonist and of sibutramine, the pharmaceutical compositions comprising them and their use in the treatment of obesityAVENTIS PHARMA SA·Filed 2007·Application pending·0 cites
- 0563US2006258709A1Combination of a cb1 receptor antagonist and of sibutramine, the pharmaceutical compositions comprising them and their use in the treatment of obesityAVENTIS PHARMA SA·Filed 2006·Application pending·0 cites
- 0650US2002091114A1Combination of a CB1 receptor antagonist and of sibutramine, the pharmaceutical compositions comprising them and their use in the treatment of obesityFiled 2001·Application pending·0 cites
- 0748US2007197654A1Combination of a cb1 receptor antagonist and of a product which activates dopaminergic neurotransmission in the brain, the pharmaceutical compositions comprising them and their use in the treatment of parkinson's diseaseAVENTIS PHARMA SA·Filed 2007·Application pending·0 cites
- 0846US7105504B2Combination of a CB1 receptor antagonist and of a product which activates dopaminergic neurotransmission in the brain, the pharmaceutical compositions comprising them and their use in the treatment of parkinson's diseaseAVENTIS PHARMA SA·Filed 2004·Granted Sep 12, 2006·0 cites·22 claims
Join the waitlist — get patent alerts
Get an alert when Odile Piot-Grosjean files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →